Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study.
William John YaxleyTroy GianduzzoBoon KuaRachel OxfordJohn William YaxleyPublished in: Investigative and clinical urology (2022)
Focal primary IRE for prostate cancer is associated with 90% infield ablation of any ISUP grade >2 cancer with a low risk of urinary incontinence or impotence. Surveillance prostate biopsies are required to exclude progression despite a normal post-IRE multiparametric magnetic resonance imaging (mpMRI). Salvage IRE is a promising option for localised recurrence after prostate radiotherapy with low morbidity.
Keyphrases
- prostate cancer
- radical prostatectomy
- urinary incontinence
- endoplasmic reticulum stress
- magnetic resonance imaging
- papillary thyroid
- early stage
- public health
- computed tomography
- rectal cancer
- locally advanced
- radiation therapy
- squamous cell
- squamous cell carcinoma
- young adults
- benign prostatic hyperplasia
- contrast enhanced
- radiofrequency ablation
- atrial fibrillation